Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 604-351-6 | CAS number: 143390-89-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Neurotoxicity
Administrative data
- Endpoint:
- neurotoxicity: acute oral
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP / Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-8 (Neurotoxicity Screening Battery)
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- methyl (2E)-2-methoxyimino-2-[2-[(2-methylphenoxy)methyl]phenyl]acetate
- EC Number:
- 604-351-6
- Cas Number:
- 143390-89-0
- Molecular formula:
- C18 H19 N O4
- IUPAC Name:
- methyl (2E)-2-methoxyimino-2-[2-[(2-methylphenoxy)methyl]phenyl]acetate
- Details on test material:
- - Name of test material (as cited in study report): Reg. No. 242 009
- Physical state: powder / light brown
- Analytical purity: 92.7 %
- Stability under test conditions: was proven by re-analysis
- Lot/batch No.: N 36 = IIIc1
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Dr. Karl Thomae AG, Biberach, Germany
- Age at study initiation: 42 days
- Mean weight at study initiation: males: 190g; females: 147g
- Housing: Type DK III, stainless steel wire cages; floor area ~ 800 cm2; individual housing
- Diet (e.g. ad libitum): Kliba rats/mice/hamsters maintenance palleted diet; Klingenthalmuehle AG, Kaiseraugust, Switzerland; ad libitum (except FOB / motor activity test)
- Water (e.g. ad libitum): tap water; ad libitum (except FOB / motor activity test)
- Acclimation period: at least 9 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Vehicle: 0.5% aqueous carboxymethyl cellulose (CMC). Administration volume: 10 ml/kg bw. - Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- single administration
- Frequency of treatment:
- single administration
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 500, 1000, 2000 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent vehicle
Examinations
- Observations and clinical examinations performed and frequency:
- Observations
The general state of health of the animals was checked twice daily on working days and once daily on weekends and public holidays. Furthermore, the animals were examined in detail and palpated once a week (see FOB examinations).
Body weight
The body weight of the animals was determined before the first FOB and motor activity measurement in order to randomise the animals (pre-exposure body weights on Day -6). Thereafter, body weights were determined on Day 0 (start of the administration period) and then at weekly intervals. The difference between the body weight on the respective day of weighing and the body weight on Day 0 was calculated as body weight change.
Food consumption
Effects on food consumption were not examined. - Neurobehavioural examinations performed and frequency:
- Functional observation battery (FOB) and Motor activity
A functional observational battery was performed with each animal on study on Day -6, on Day 0 (starting 2 hours after gavage), on Day 7 and Day 14. The FOB started with passive observations without disturbing the animals; followed by removal from the home cage, open field observations in a standard arena, sensorimotor tests and reflex tests as well as quantitative measurements. The findings were ranked according to the degree of severity, if applicable. The observations were performed blinded and in randomised order.
The parameters determined are given in the listing in table 1.
Motor activity was measured on the same day as the FOB. The measurement was performed in the dark using the Multi-Varimex System (Columbus Instruments Intl. Corp., Ohio, USA) with four infrared beams per cage. The measurements started at about 14:00 h (ca. 6 hours after gavage). The number of beam interrupts was counted over 12 intervals, each lasting five minutes. During the measurements the animals received no food and no water. - Sacrifice and (histo)pathology:
- Sacrifice and neuropathology
At the end of the study period, 14 days after gavage administration, five animals per sex and test group were deeply anesthetized (Nembutal, ca. 4 ml/kg bw) and sacrificed by perfusion fixation. The sacrificed animals were necropsied and the visible organs assessed by gross pathology as thoroughly as possible for perfused animals. Soerensen's phosphate buffer served as rinsing solution and Karnovsky was used as fixation solution.
With the exception of peripheral nerve specimen, all the tissues listed in the table below from perfused animals of the control and high-dose group were embedded in Paraplast (paraffin).
See table 2 for tissues examined.
Peripheral nerve samples from all 5 of the perfused control group and high-dose group animals from each sex were embedded in epoxiresin-based plastic. Semi-thin cross and longitudinal sections were prepared and stained with toluidine blue before light-microscopical examination. Fixed peripheral nerve specimens from the low- and mid-dose group were stored in buffer solution but not further processed or evaluated.
Cross and/or oblique sections were prepared and stained with hematoxylin/eosin (H&E), followed by assessment of the tissue sections by light microscopy. Tissue samples from perfused rats of the low- and mid-dose group were preserved in neutral buffered 4% formaldehyde solution but not further processed or evaluated.
All animals not subjected to perfusion fixation were sacrificed under CO2 anesthesia without further examinations. - Positive control:
- Positive control data:
The examinations were carried out by trained technicians which performed positive control studies as part of their training. Acrylamide, Trimethyltin chloride, 3,3'-Iminodiproprionitril, Carbaryl, Nomifensin and Diazepam were used as positive control compounds. In the positive control studies, behavioral and neuropathological sequelae of substances with nervous system effects were evaluated using Functional Observational Batteries (FOB), Motor Activity Measurements and Neuropathology. Clinical signs of peripheral neuropathy (e.g. ataxia, limb weakness), central neuropathy (e.g. tremors) and autonomic signs (e.g. salivation) could be shown. Histopathologically, changes in the peripheral nervous system (e.g. Wallerian-like degeneration) and central nervous system (e.g. neuronal necrosis) were seen. The motor activity device could show both increased and decreased activity. The interobserver reliability of the technicians performing functional observational batteries was proven. Summaries of the positive control studies are presented in the study report - Statistics:
- Body weight: Parametric one-way analysis of variance via the (2-sided) F-test (ANOVA). If the resulting p-value was equal or less than 0.05, a pairwise comparison of each dose group with the control group was performed using the DUNNETT's test (2-sided) for the hypothesis of equal means.
Quantitative FOB parameters and motor activity: Non-parametric one-way analysis using the KRUSKAL-WALLIS test. If the resulting p-value was equal or less than 0.05, a pairwise comparison of each dose group with the control group was performed using MANN-WHITNEY U-test (two sided) for the equal medians
Results and discussion
Results of examinations
- Details on results:
- Clinical signs of toxicity: No abnormal clinical signs were detected.
BODY WEIGHT
No statistically significant or biologically relevant deviation from body weight control group values was observed development was not impaired in males or females at any dose level (see table 1).
Mortality: No deaths occurred during the study.
Functional Observational Battery (FOB):
- Home cage observations: No substance-related effects were observed.
- Open field observations: No substance-related effects were observed.
- Sensormotor tests / reflexes: Grip strength of forelimbs was decreased statistically significant in high and mid dose females on Day 14. However, as the values were very close to the control values, a biologically significant effects is not very plausible. Moreover, all values were well within the historical range. Thus, these findings were assessed as being only statistically, but not biologically relevant. A substance-related effect can therefore be excluded.
No statistically significant deviations were obtained in any of the other dose groups. In summary, no substance-related findings were observed in any part of the functional observation battery.
Motor Activity Measurement
Regarding the overall motor activity the values were statistically significantly increased in high and mid dose males on day -6, and in high dose males on day 14. However, as there was no dose-response relationship and as the changes were observed even prior to treatment, this was assessed as being incidental.
Comparing the single intervals with the control groups several values of the treatment groups (both sexes) differed statistically significantly from control values. However, as there was no dose-response relationship and the changes were observed even prior to treatment, these deviations were assessed as being incidental.
NECROPSY AND NEUROPATHOLOGY
Gross lesions: There were no gross lesions noted.
Light microscopy (neuropathology): One female test animal of the high dose (Animal-No. 73) showed a minimal axonal degeneration of the proximal sciatic nerve, which is seen to be a spontaneous lesion for reasons as follows:
- No further high dose test animals are concerned
- no further nerve fiber samples in this test animal are concerned,
- the lesion is not a specific neurotoxic effect and it is minimal in grading.
The light-microscopic investigation did not reveal any substance-dependent changes in the organ samples examined. Especially, no substance-induced neuropathological lesions could be detected.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 2 000 other: mg/kg bw
- Sex:
- male/female
- Remarks on result:
- other:
Any other information on results incl. tables
|
Males |
Females |
||||||
Dose level [mg/kg bw] |
0 |
500 |
1000 |
2000 |
0 |
500 |
1000 |
2000 |
Body weight [g] |
||||||||
Day -6 [g] (%) |
134.2 (100) |
134.2 (100) |
133.7 (99.6) |
134.4 (100.2) |
115.7 (100) |
115.3 (99.6) |
114.5 (98.9) |
115.2 (99.6) |
Day 0 [g] (%) |
189.2 (100) |
185.1 (97.8) |
195.1 (103.1) |
189.3 (100.1) |
148.0 (100) |
147.1 (99.4) |
146.4 (98.9) |
147.7 (99.8) |
Day 7 [g] (%) |
235.9 (100) |
227.5 (96.4) |
246.1 (104.3) |
238.4 (101.0) |
169.1 (100) |
169.1 (100) |
169.4 (100.2) |
172.8 (102.2) |
Day 14 [g] (%) |
280.3 (100) |
266.0 (94.9) |
292.2 (104.2) |
283.5 (101.2) |
188.0 (100) |
186.0 (101.0) |
189.9 (101.0) |
189.7 (100.9) |
Statistical evaluation: * p=< 0.05, ** p =< 0.01 (Dunnett's test, 2-sided) |
Table 1: Body weight.
Historical control data - Grip strength forelimbs |
|||
Age: |
6 weeks |
7 weeks |
8 weeks |
FIRST MEASUREMENT (Newton) |
|||
Males |
2.8 (1.5 – 4.2) |
3.3 (1.4 – 5.0) |
3.8 (1.6 – 5.2) |
Females |
2.8 (1.4 – 4.2) |
3.3 (1.8 – 4.8) |
3.3 (2.0 – 5.0) |
SECOND MEASUREMENT (Newton) |
|||
Males |
2.9 (1.8 – 4.5) |
3.3 (1.4 – 5.3) |
3.7 (1.8 – 5.8) |
Females |
2.9 (1.8 – 4.2) |
3.4 (1.8 – 5.0) |
3.4 (1.8 – 5.6) |
Data is given as mean (Newton) and minimum-maximum range (in brackets) 19 studies with Wistar rats from the BASF test facility |
|
Males |
Females |
||||||
Dose level [mg/kg bw] |
0 |
500 |
1000 |
2000 |
0 |
500 |
1000 |
2000 |
Grip strength forelimbs [Newton] |
||||||||
Day -6 [N] (%) |
2.7 (100) |
2.3 (82.7) |
2.7 (99.6) |
2.8 (100.7) |
3.4 (100) |
3.1 (90.9) |
2.8 (83.5) |
3.2 (95.0) |
Day 0 [N] (%) |
3.2 (100) |
3.0 (92.5) |
3.4 (106.3) |
3.3 (104.1) |
3.4 (100) |
3.3 (95.9) |
3.5 (103.2) |
3.4 (99.7) |
Day 7 [N] (%) |
3.8 (100) |
3.8 (101.1) |
3.9 (101.9) |
3.8 (101.1) |
3.3 (100) |
3.2 (96.8) |
3.2 (95.8) |
3.1 (92.4) |
Day 14 [N] (%) |
3.9 (100) |
3.6 (91.4) |
3.9 (99.0) |
3.8 (95.9) |
3.4 (100) |
3.3 (98.2) |
3.0* (87.6) |
2.9** (86.7) |
Statistical evaluation: * p£ 0.05, ** p£ 0.02; *** p£ 0.002 (Kruskal-Wallis, 2-sided) |
Table 2: Grip strength forelimbs
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.